Daily Calcium Intervention for a Weight-Loss Program Resulted in More Significant Decreases in Body Weight, BMI, Body Fat Mass, and Body Fat Percentage

Authors

  • Yen-Ling Chen Department of Internal Medicine, Division of Metabolism and Endocrinology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan, ROC
  • Yi-Chun Chen School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan, ROC
  • Jung-Su Chang School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan, ROC
  • Jo Chun Lin School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan, ROC
  • Yi-Wen Chien School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan, ROC

DOI:

https://doi.org/10.17140/OROJ-2-112

Keywords:

Obesity; Energy restricted diet; Weight loss; Calcium; Parathyroid hormone (PTH).

Abstract

The purpose of this study was to assess of calcium intervention on the effectiveness
of a weight-loss program for obese people. All subjects had an initial BMI (body mass index)
>24 kg/m2
and low calcium diet (<500 mg/d). Forty-two healthy overweight or obese people
were randomly and equally divided into two groups: a Hi-Ca group (female: 16, male: 5) and
a control group (female: 16, male: 5). In the Hi-Ca group, we provided two bottles of Hi-Ca
drinks per day and a low energy diet (energy: 1200 kcal, carbohydrate: 55%, fat: 25%, protein:
20%) for eight weeks. In the control group, we only provided the low energy diet for eight
weeks. We measured three-day food records, anthropometric and blood biochemical data at
Weeks 0 and 8. Calcium intake was 964.5±75.5 mg in the Hi-Ca group and was 353.7±96.6
mg in the control group (p<0.05). After eight weeks, results showed the loss of body weight
(-6.9±3.3 kg, p<0.05), BMI (-2.7±1.1 kg/m2
, p<0.01), body fat mass (-5.7±2.7 kg, p<0.05),
body fat percentage (-4.4±1.9 %, p<0.002) and TC/HDL-C (-0.4±0.6, p<0.05) in the Hi-Ca
group were significantly different from those of the control group at eight weeks. In the lipid
profile, serum cholesterol, triglycerides and LDL-C concentration were significantly decreased
compared with Week 0. The serum PTH (parathyroid hormone) levels in the Hi-Ca group were
significantly lower compared with baseline (-5.3±10.4 pg/mL, p<0.05), which showed that the
concentration of PTH and calcium intake are negatively correlated, and indicate that a highcalcium low-energy diet resulted in more significant decreases in body weight, BMI, body fat
mass, and body fat percentage. Therefore, a high calcium diet increases the effectiveness of an
energy-restricted diet for weight loss in overweight people.

References

Sakhaee K, Maalouf NM. Dietary calcium, obesity and hyper-tension--the end of the road? J Clin Endocrinol Metab. 2005; 90: 4411-4413. doi: 10.1210/jc.2005-1004

McLaughlin T, Carter S, Lamendola C, et al. Effects of mod-erate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resis-tant adults. Am J Clin Nutr. 2006; 84: 813-821.

Bougoulia M, Triantos A, Koliakos G. Effect of weight loss with or without orlistat treatment on adipocytokines, inflamma-tion, and oxidative markers in obese women. Hormones (Ath-ens). 2006; 5: 259-269.

Barbato KB, Martins Rde C, Rodrigues Mde L, Braga JU, Francischetti EA, Genelhu V. Effects of greater-than-5% weight reduction on hemodynamic, metabolic and neuroendocrine pro-files of grade I obese subjects. Arq Bras Cardiol. 2006; 87: 12- 21. doi: 10.1590/S0066-782X2006001400003

Teegarden D. Calcium intake and reduction in weight or fat mass. J Nutr. 2003; 133: 249s-251s.

Kumada M, Kihara S, Sumitsuji S, et al. Association of hy-poadiponectinemia with coronary artery disease in men. Arte-rioscler Thromb Vasc Biol. 2003; 23: 85-89. doi: 10.1161/01. ATV.0000048856.22331.50

Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin re-sistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001; 86: 1930-1935.

Selwyn AP. Weight reduction and cardiovascular and meta-bolic disease prevention: clinical trial update. Am J Cardiol. 2007; 100: 33-37.

Zemel MB, Thompson W, Milstead A, Morris K, Campbell P. Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res. 2004; 12: 582-590.

Parikh SJ, Yanovski JA. Calcium intake and adiposity. Am J Clin Nutr. 2003; 77: 281-287.

Shahar DR, Abel R, Elhayany A, Vardi H, Fraser D. Does dairy calcium intake enhance weight loss among overweight dia-betic patients? Diabetes Care. 2007; 30: 485-489. doi: 10.2337/ dc06-1564

Zemel MB. Role of calcium and dairy products in energy partitioning and weight management. Am J Clin Nutr. 2004; 79: 907-912.

Pereira MA, Jacobs DR, Jr., Van Horn L, Slattery ML, Kartashov AI, Ludwig DS. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA. 2002; 287: 2081-2089. doi: 10.1001/jama.287.16.2081

Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346: 393-403. doi: 10.1056/ NEJMoa012512

Zemel MB, Richards J, Milstead A, Campbell P. Effects of calcium and dairy on body composition and weight loss in Afri-can-American adults. Obes Res. 2005; 13: 1218-1225.

Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regula-tion of adiposity by dietary calcium. FASEB J. 2000; 14: 1132- 1138.

McCarron DA, Morris CD, Henry HJ, Stanton JL. Blood pressure and nutrient intake in the United States. Science. 1984; 224: 1392-1398. doi: 10.1126/science.6729459

Denke MA, Sempos CT, Grundy SM. Excess body weight. An underrecognized contributor to high blood cholesterol lev-els in white American men. Arch Intern Med. 1993; 153: 1093- 1103. doi: 10.1001/archinte.1993.00410090045006

Shapses SA, Heshka S, Heymsfield SB. Effect of calcium supplementation on weight and fat loss in women. J Clin Endo-crinol Metab. 2004; 89: 632-637. doi: 10.1210/jc.2002-021136

Barr SI. Increased dairy product or calcium intake: is body weight or composition affected in humans? J Nutr. 2003; 133: 245s-248s.

Barba G, Russo P. Dairy foods, dietary calcium and obe-sity: a short review of the evidence. Nutr Metab Cardiovasc Dis. 2006; 16: 445-451.

Zemel MB. The role of dairy foods in weight management. J Am Coll Nutr. 2005; 24: 537s-546s.

Teegarden D, Zemel MB. Dairy product components and weight regulation: symposium overview. J Nutr. 2003; 133: 243s-244s.

Drew BS, Dixon AF, Dixon JB. Obesity management: up-date on orlistat. Vasc Health Risk Manag. 2007; 3: 817-821.

Huth PJ, DiRienzo DB, Miller GD. Major scientific advanc-es with dairy foods in nutrition and health. J Dairy Sci. 2006; 89: 1207-1221. doi: 10.3168/jds.S0022-0302(06)72190-7

Thompson WG, Rostad Holdman N, Janzow DJ, Slezak JM, Morris KL, Zemel MB. Effect of energy-reduced diets high in dairy products and fiber on weight loss in obese adults. Obes Res. 2005; 13: 1344-1353.

Xue B, Greenberg AG, Kraemer FB, Zemel MB. Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in hu-man adipocytes. FASEB J. 2001; 15: 2527-2579.

Xue B, Moustaid N, Wilkison WO, Zemel MB. The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism. FASEB J. 1998; 12: 1391-1396.

Kim JH, Mynatt RL, Moore JW, Woychik RP, Moustaid N, Zemel MB. The effects of calcium channel blockade on agouti-induced obesity. FASEB J. 1996; 10: 1646-1652.

Vaskonen T. Dietary minerals and modification of cardio-vascular risk factors. J Nutr Biochem. 2003; 14: 492-506. doi: 10.1016/S0955-2863(03)00074-3

Devraj R, Williams HD, Warren DB, Mullertz A, Porter CJ, Pouton CW. In vitro digestion testing of lipid-based delivery systems: calcium ions combine with fatty acids liberated from triglyceride rich lipid solutions to form soaps and reduce the sol-ubilization capacity of colloidal digestion products. Int J Pharm. 2013; 441: 323-333. doi: 10.1016/j.ijpharm.2012.11.024

Christensen R, Lorenzen JK, Svith CR, et al. Effect of cal-cium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev. 2009; 10: 475-486. doi: 10.1111/j.1467-789X.2009.00599.x

Buchowski MS, Aslam M, Dossett C, Dorminy C, Choi L, Acra S. Effect of dairy and non-dairy calcium on fecal fat excre-tion in lactose digester and maldigester obese adults. Int J Obes (Lond). 2010; 34: 127-135. doi: 10.1038/ijo.2009.212

Reid IR. Effects of calcium supplementation on circulating lipids: potential pharmacoeconomic implications. Drugs Aging. 2004; 21: 7-17.

Saunders D, Sillery J, Chapman R. Effect of calcium carbon-ate and aluminum hydroxide on human intestinal function. Dig Dis Sci. 1988; 33: 409-413.

Van der Meer R, Welberg JW, Kuipers F, et al. Effects of supplemental dietary calcium on the intestinal association of calcium, phosphate, and bile acids. Gastroenterology. 1990; 99: 1653-1659.

Forti N, Diament J. High-density lipoproteins: metabolic, clinical, epidemiological and therapeutic intervention aspects. An update for clinicians. Arq Bras Cardiol.2006; 87: 671-679.

Layman DK, Boileau RA, Erickson DJ, et al. A reduced ratio of dietary carbohydrate to protein improves body composition and blood lipid profiles during weight loss in adult women. J Nutr. 2003; 133: 411-417.

Josse AR, Atkinson SA, Tarnopolsky MA, Phillips SM. In-creased consumption of dairy foods and protein during diet- and exercise-induced weight loss promotes fat mass loss and lean mass gain in overweight and obese premenopausal women. J Nutr. 2011; 141: 1626-1634. doi: 10.3945/jn.111.141028

McGregor RA, Poppitt SD. Milk protein for improved meta-bolic health: a review of the evidence. Nutr Metab (Lond). 2013; 10: 46. doi: 10.1186/1743-7075-10-46

Alemzadeh R, Kichler J. Parathyroid hormone is associated with biomarkers of insulin resistance and inflammation, inde-pendent of vitamin D status, in obese adolescents. Metab Syndr Relat Disord. 2012; 10: 422-429.

Ishimura E, Okuno S, Tsuboniwa N, et al. Significant posi-tive association between parathyroid hormone and fat mass and lean mass in chronic hemodialysis patients. J Clin Endocrinol Metab. 2013; 98: 1264-1270. doi: 10.1210/jc.2012-3883

Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study. Eur J Endocrinol. 2004; 151: 167-172.

Parikh SJ, Edelman M, Uwaifo GI, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concen-trations in healthy adults. J Clin Endocrinol Metab. 2004; 89: 1196-1199. doi: 10.1210/jc.2003-031398

Ni Z, Smogorzewski M, Massry SG. Effects of parathyroid hormone on cytosolic calcium of rat adipocytes. Endocrinology. 1994; 135: 1837-1844. doi: 10.1210/endo.135.5.7525254

Gunther CW, Lyle RM, Legowski PA, et al. Fat oxidation and its relation to serum parathyroid hormone in young women enrolled in a 1-y dairy calcium intervention. Am J Clin Nutr. 2005; 82: 1228-1234.

Teegarden D. The influence of dairy product consumption on body composition. J Nutr. 2005; 135: 2749-2752.

Snijder MB, van Dam RM, Visser M, et al. Adiposity in rela-tion to vitamin D status and parathyroid hormone levels: a pop-ulation-based study in older men and women. J Clin Endocrinol Metab. 2005; 90: 4119-4123. doi: 10.1210/jc.2005-0216

Downloads

Published

2015-08-19

How to Cite

Yen-Ling Chen, Yi-Chun Chen, Jung-Su Chang, Jo Chun Lin, & Yi-Wen Chien. (2015). Daily Calcium Intervention for a Weight-Loss Program Resulted in More Significant Decreases in Body Weight, BMI, Body Fat Mass, and Body Fat Percentage. Obesity Research, 73–80. https://doi.org/10.17140/OROJ-2-112

Issue

Section

Articles